Introduction: The New Tariff Landscape
The 2025 US tariff regime, which involves reciprocal tariff duties as high as 26% on Indian exports, has redefined and reshaped the India-US trade landscape. A uniform 26% tariff was implemented across most Indian exports to the US. Certain sectors, including pharmaceuticals and critical minerals, remain exempt. Even if these reciprocal tariffs remain near the 25–26% mark, India still holds a competitive edge over China, Bangladesh, Vietnam, and Thailand.
Sector-Wise Impact
Automobiles & Auto Components — Tariff: 25–26%
India's leading auto components exporters, dependent on the US for 27% of value, face steep export declines and renegotiated contracts. EV suppliers may face delays in expansion. Domestic auto sales may rise marginally if firms redirect capacity homeward.
Steel & Aluminium — Tariff: 25%
Exporters deal with eroding margins and sluggish demand. If India imposes counter-tariffs on China to avoid being flooded with cheap Chinese steel, domestic steel prices will rise — harming construction, real estate, and infrastructure.
Textiles & Apparel — Tariff: 26%
Margin pressure is immediate, risking a 10–12% decline in exports. However, India's relatively moderate tariff compared to China and Vietnam may offer a strategic advantage in the medium term as buyers diversify sources.
Pharmaceuticals — Exempted
Secure from new duties, India retains its significant role as a major US supplier. Market share may even expand as rivals face higher barriers to entry.
Gems & Jewellery — Tariff: 26%
Sales to the US, India's biggest market, could drop 15% or more. Any change to duty-free diamond access would have a profoundly negative impact on the Surat-based industry.
Agriculture & Marine — Tariff: 26%
Marine products and specialty crops experience a significant volume decline. Domestic price drops may harm farmer incomes unless the government intervenes with minimum support prices or subsidies.
Mutual Fund Industry Response
Exporters in the auto, metal, and textile sectors suffered sharp corrections, whereas pharmaceuticals and domestic consumption players outperformed. Despite headline risks, mutual fund inflows — especially from systematic investors — remain robust. Sector-specific funds exposed to exports have disappointed. Defensive rotation into pharma, chemicals, and domestic themes is evident.
Conclusion: Navigating Uncertainty, Finding Opportunity
The 2025 US tariffs have disrupted India's export map, with diverse effects across industries. Financial markets are responding with caution but have not yet seen panic, and mutual funds are demonstrating resilience by adjusting sectoral exposures. The evolving global scenario underscores the need for strategic agility and continued focus on India's robust domestic growth story as a buffer against global turbulence.